Several studies have used macaque monkeys with lesions induced in the primary motor cortex (M1) to investigate the recovery of motor function after brain damage. However, in human stroke patients, the severity and outcome of motor impairments depend on the degree of damage to the white matter, especially that in the posterior internal capsule, which carries corticospinal tracts. To bridge the gap between results obtained in M1-lesioned macaques and the development of clinical intervention strategies, we established a method of inducing focal infarcts at the posterior internal capsule of macaque monkeys by injecting endothelin-1 (ET-1), a vasoconstrictor peptide. The infarcts expanded between 3 days and 1 week after ET-1 injection. The infarct volume in each macaque was negatively correlated with precision grip performance 3 days and 1 week after injection, suggesting that the degree of infarct expansion may have been a cause of the impairment in hand movements during the early stage. Although the infarct volume decreased and gross movement improved, impairment of dexterous hand movements remained until the end of the behavioral and imaging experiments at 3 months after ET-1 injection. A decrease in the abundance of large neurons in M1, from which the descending motor tracts originate, was associated with this later-stage impairment. The present model is useful not only for studying neurological changes underlying deficits and recovery but also for testing therapeutic interventions after white matter infarcts in primates.
Introduction
Several studies, including ours, have used macaque monkeys with lesions induced in the primary motor cortex (M1) to investigate the recovery of motor function after brain damage [1] [2] [3] [4] [5] [6] [7] [8] . M1 lesions specifically impair motor function, leaving sensory and cognitive functions intact; they are therefore suitable for investigating changes in neural structure and function that are associated with deficits and recovery of motor behavior. However, in human stroke patients, the severity and outcome of motor impairments depend on the degree of damage to the white matter, especially that in the posterior internal capsule, which carries corticospinal tracts [9] [10] [11] . Thus, to bridge the gap between the results obtained in M1-lesioned macaques and the development of clinical intervention strategies, it is important to establish a nonhuman primate model of focal stroke at the posterior internal capsule.
Several models of focal stroke at the internal capsule have been established in the rat [12] [13] [14] [15] and miniature pig [16] . Recently, an internal capsule stroke model was also produced in the common marmoset [17] , a small non-human primate species used widely in basic and clinical research because of its ease of handling and breeding. These models are useful for studying the neurological changes underlying behavioral deficits and recovery after stroke in the white matter. However, the macaque has an advantage over other experimental animals because it is more compatible with humans with regard to both molecular and anatomical features of the motor cortex and corticospinal tract than other species used experimentally, including squirrel monkeys and marmosets, thus making the findings more applicable to human patients [18] [19] [20] [21] . Here, we established a method of inducing focal infarcts at the posterior internal capsule by injecting endothelin-1 (ET-1), a vasoconstrictor peptide [22] , and investigated behavioral and histological changes after injection.
Materials and Methods

Animals
Ten Japanese macaques (Macaca fuscata, eight males and two females, 4.2 to 8.8 kg, > 4 years in age) were randomly assigned to one of five survival periods, namely 4 days, 2 weeks, 3 weeks, 1 month, and 3 months, after ET-1 injection. Two macaques (two males, 4.2 and 6.3 kg) died within few hours after ET-1 injection due to respiratory failure, and the remaining eight macaques were used for the present analysis (Table 1 ). Brain tissues were also obtained from six intact Japanese macaques (four males and two females, 3.1 to 8.9 kg) as controls for histological analysis. The macaques were either purchased from a local provider (Kawahara BirdAnimal Trading Co. Ltd., Tokyo, Japan) or bred in the Primate Research Institute of Kyoto University. No statistical methods were used to pre-determine sample sizes. We attempted to minimize the number of monkeys used on the basis of ethical considerations and data similarity; our sample sizes are similar to those reported in previous publications by our group and others. Naive macaques without any history of experimentation were used.
The animal use protocol, including the mortality aspects, was reviewed and approved by the Institutional Animal Care and Use Committee of the National Institute of Advanced Industrial Science and Technology (AIST), Japan (#2012-049), conformed to the NIH Guidelines for the Care and Use of Laboratory Animals and ARRIVE guidelines (S1 ARRIVE Guidelines Checklist). Our procedure also followed the recommendations of the Weatherall report [23] . The macaques were housed in adjoining individual primate cages allowing social interactions under controlled conditions of humidity, temperature, and light; they were monitored daily by the researchers and animal care staff to ensure their health and welfare. The housing area was maintained on a 12-h light-12-h dark cycle, and all of the experiments were conducted during the light cycle. A commercial primate diet and fresh fruit and vegetables were provided daily, and water was provided in a drinking bottle and freshened daily. Environmental enrichment consisted of commercial toys and a platform placed at the middle of the cage wall which enabled the macaques to freely move up and down. All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering. Endpoint criteria, as defined by the study protocol, were used to determine when animals should be humanely euthanized; macaques found in a moribund condition and those showing severe pain and/or enduring signs of severe distress should be humanely euthanized. Two macaques died within few hours after ET-1 injection as described above. They died before awakening from anesthesia without showing any signs of pain or distress. No macaque met the humane endpoint criteria in the present study.
ET-1 Injection
We first determined the preferred hand of macaques by recording the hand that was used for reaching and grasping the target object, as in our previous studies [1, 2] . We then injected ET-1 into the posterior internal capsule of the hemisphere contralateral to the preferred hand. The location of the posterior internal capsule where the fibers from the M1 hand area descend was identified by using anatomical structures such as the central sulcus, thalamus, caudate nucleus, and putamen on the basis of data from anatomical tracer studies [24, 25] . The anatomical structure of each macaque's brain was visualized on magnetic resonance images (MRI) obtained by using a 3.0-T MRI system (3T Signa LX; General Electric Medical Systems, Milwaukee, WI). Before the scan, the animals were anesthetized with medetomidine (0.05 mg/kg), midazolam (0.3 mg/kg), and ketamine (4 mg/kg) and fixed into a magnet-free stereotactic frame. The imaging protocols consisted of a T1-weighted spoiled gradient-echo sequence, repetition time (TR)/echo time (TE), 50.0/9.0 ms; number of excitations (NEX), 1; flip angle, 45°; field of view, 120 mm × 120 mm; matrix, 256 × 192; slice thickness, 1.2 mm, and a T2-weighted fast spin echo sequence, TR/TE, 5000/102 ms; NEX, 4; flip angle, 90°; field of view, 120 mm × 120 mm; matrix, 256 × 256; slice thickness, 1.5 mm,. After incision of the head skin, the skull was exposed and an MR-compatible chamber was attached to the skull under sterile conditions and pentobarbital anesthesia (25 mg/kg). A craniotomy was made over the internal capsule, and ET-1 (1.5 μg/μL, 4198-v, Peptide Institute, Inc., Osaka, Japan) was then injected via a microsyringe. A total of 15 injections were performed at three injection sites, separated by 1.5 mm in a dorsoventral direction, in each of five rostral-caudal tracks, which were also separated by 1.5 mm. The injection sites were centered at the identified stereotaxic coordinates for the posterior internal capsule where the motor tracts from the hand area of M1 descend (i.e., the white matter lateral to the caudate nucleus and medial to the putamen in the coronal section 3 mm caudal to the rostrocaudal level where the rostral end of the central sulcus was seen). The mean stereotaxic coordinates of the center of the injection sites were 16.6 ± 3.7 (SD) mm rostral, 11.2 ±1.8 mm lateral, and 14.3 ± 2.0 mm below the dura. At each injection site, 8 μL ET-1 was injected at a rate of 2 μL per min. After injection, the needle was retained for 10 min to allow the solution to disperse and minimize backflow through the needle track.
Behavioral Assessment
Performance of hand movements before and after the ET-1 injections was evaluated daily by means of a small-object retrieval task closely resembling that used in our previous studies [1, 2] . In the test session with this task, the macaques retrieved a small piece of sweet potato (7 × 7 × 7 mm in size) attached to a needle tip in a cylindrical tube (20 mm in diameter) for 20 trials. The cylindrical tube was located at shoulder height and at a sagittal distance of 150 mm from the cage. The macaque's movements were recorded by four video cameras (one HDC-TM350 camera, Panasonic, Osaka, Japan; three WAT-902H Ultimate cameras, Watec, Tsuruoka, Japan) installed around the task apparatus. We calculated the percentage of retrieval, i.e., grasping and eating the food piece/pellet without dropping it, and that of precision grip, defined as grasping the food piece between the pads of the tips of the index finger and thumb without using other digits or the palm.
Infarct Size Assessment and Histology
To evaluate spatiotemporal changes in the infarcts, MRI scans were performed before ET-1 injection and 1 day, 3 days, 1 week, 2 weeks, 1 month, and 3 months after injection. The MRI protocols were the same as described above. The area of infarct was seen as a hypointense infarct core with a surrounding hyperintense rim on T2-weighted MR images, as in previous studies [26] [27] [28] [29] . The unbiased volumes of the infarct were calculated on the basis of Cavalieri's principle [30] by using StereoInvestigator imaging software (MBF Bioscience, Williston, VT). The tracks of the injection needles were often visible as hyperintensities in T2-weighted images ( Fig 1A) . No hyperintensity was observed in the macaque used in a pilot study in which the needle was inserted, but no ET-1 was injected to confirm accurate localization of the needle tip in the posterior internal capsule (data not shown). Therefore, the hyperintense tracks were thought to result from the backflow of ET-1, although we attempted to minimize the backflow of ET-1 through the needle tracks, as described above. We included the hyperintense tracks in the infarct volume measures. In addition, changes in the neuronal structure in layer V of M1 were evaluated by histological analysis. Tissue preparation was performed as previously described [31] . The macaque monkeys were deeply anesthetized with sodium pentobarbital (35-50 mg/kg, i.v.) and then perfused through the ascending aorta with 0.5 L of ice-cold saline containing sodium heparin (1000 units/mL), followed by ice-cold fixative consisting of 4% paraformaldehyde and 0.1% glutaraldehyde in phosphate buffer (pH 7.4). The volume of fixative perfused was 1 L/kg body weight. After perfusion, coronal sections (16 μm thickness) were made at the level of the superior genu of the central sulcus, as in our previous studies [3, 20, 32, 33] . We measured the size of the neuronal cell bodies in layer V of M1 by using a procedure similar to that used in our previous studies [3, 32, 33] . Briefly, the Nissl-stained sections were digitized by using StereoInvestigator imaging software (MBF Bioscience). We then measured the size of 50 neuronal cell bodies from layer V of the forelimb area of M1, within 3 mm of the central sulcus on coronal sections, by using Image J software (National Institutes of Health, Bethesda, MD). The measurements were performed by a person blinded to the treatment of the macaques.
Statistical Analyses
Statistical significance was assessed by nonparametric tests including the Mann-Whitney Utest and Kruskal-Wallis one-way analysis of variance followed by Dunn's post-hoc test.
Results
The area of infarct 1 day after injection included the posterior internal capsule, where the motor tracts from the hand area of M1 descend (arrows in Fig 1A; i.e., the white matter lateral to the caudate nucleus/thalamus and medial to the putamen/globus pallidus on coronal sections from the rostrocaudal level, which includes the rostral end of the central sulcus to that, which includes the superior genu of the central sulcus) [24, 25] . The median and interquartile range of the percentage of infarct volume within the internal capsule was 82.3 [79.6-83.8] ( Table 1 ). The infarct expanded between 3 days and 1 week; it then decreased until the end of the behavioral experiment at 3 months after ET-1 injection (Fig 1B, 1C and 1D) .
Before ET-1 injection, all animals performed the small-object retrieval task smoothly using a precision grip, holding the morsel between the tips of the index finger and thumb (Fig 2A) . Immediately after ET-1 injection, impairment of motor function in the contralateral forelimb was observed. There was no apparent impairment of movement of other body parts, such as the face or hindlimb, and the macaques showed no apparent difficulty in eating, drinking, or moving. The macaques showed impaired performance in the small-object retrieval task; the rates of successful retrieval and precision grip the day after injection were below the 95% confidence level for performance before injection (Fig 2C and 2D) . The median percentage of successful retrievals in the small-object retrieval task increased rapidly over the week after injection (Fig 2C) . It increased gradually thereafter and by 3 months was within the 95% confidence interval for performance before the injection. In contrast, the percentage of precision grip was below the 95% confidence level at 3 months after injection (Fig 2D) .
After the injection, the macaques frequently retrieved the morsel using an alternative grip strategy because gross hand movements recovered whereas impairment of dexterous movements, such as independent digit movements, remained. Typically, the macaques raked out the morsel with the index finder and held it in the proximal joints of the thumb (Fig 2B) . The infarct volume of each macaque was negatively correlated with precision grip performance 3 days and 1 week after injection (P < 0.01, linear regression analysis; Fig 2E) , suggesting that individual differences in infarct volume may have accounted for the differences in hand performance. In contrast, no correlation between infarct volume and precision grip performance was observed in later periods (P > 0.05, data not shown).
As a first step in investigating changes in brain structure induced by ET-1 injection, we measured the size of neurons in layer V of M1. In the intact M1, there was an abundance of large neurons (>30 μm in diameter, Fig 3A and 3B) , from which the descending motor tracts originate [34] [35] [36] . Quantitative analysis of the percentage of neurons in each size range showed that there was a certain percentage of large neurons with a cell body area of > 500 μm 2 in the hand area of the intact M1 (Fig 3D) . In contrast, at 3 weeks after injection and beyond, there were fewer large neurons in layer V of M1 ipsilateral to the ET-1 injection site (Fig 3C) . The percentage of neuronal cell bodies larger than 500 μm 2 was significantly lower than that in the intact M1 and on the contralateral side (P < 0.05, Kruskal-Wallis one-way analysis of variance and Dunn's post hoc test; Fig 3D and 3E) . No significant change in neuronal size was observed in the contralateral M1 or in the ipsilateral M1 2 weeks or earlier after ET-1 injection (Fig 3E) . Temporal changes in infarct volume, as calculated for all ET-1 injected macaques (macaque identification numbers are given in the key). Kruskal-Wallis one-way analysis of variance indicated a significant difference of the median infarct volume among the periods after ET-1 injection (P < 0.0001), and Dunn's post-hoc tests revealed that the infarct volumes at 3 days and 1 week after injection were higher than those in the remaining periods (*P < 0.05, **P < 0.01, ****P < 0.0001). 
Discussion
Here, we induced focal infarcts in the posterior internal capsule of macaques, resulting in impaired hand movements. Because a negative correlation between infarct volume and precision grip performance was observed at both 3 days and 1 week after injection, the degree of infarct expansion may have been a cause of the impairment in hand movements during the early stage. Precision grip impairment remained several months after ET-1 injection, when the infarct volume had decreased, suggesting that irreversible changes in brain structure were present in the late stage after injection. Upper, middle, and lower rows show both top and side views at the moments when the macaque inserts the index finger through the aperture of the cylindrical tube; when the tip of the index finger contacts the food morsel; and when the macaque pulls the index finger out of the tube, respectively. Arrowhead, thumb tip; double arrowheads, index finger tip. Before ET-1 injection, use of the precision grip involving the tips of both the index finger and the thumb was observed in almost all trials. At 1 month after injection, the macaque raked out the food morsel with the index finger and then held it in the proximal joints of the thumb. (C, D) Time course of changes in the percentage of successful retrieval (C) and precision grip (D) in all of ET-1-injected macaques. Shaded gray region represents the 95% confidence interval for performance before injection. The number of successful retrievals progressively increased over the first week; by 3 months after injection, it had reached the 95% confidence level. The median value for precision grip increased gradually in the first 3 weeks after injection; it then virtually plateaued and at 3 months was still below the 95% confidence level. (E) Correlation between infarct volume and successful achievement of precision grip 3 days or 1 week after ET-1 injection. Each symbol represents data from one macaque; symbols without gray circles are data for 3 days after injection, whereas symbols with gray circles are those for 1 week after injection. The success rate in achieving a precision grip at 3 days or 1 week was negatively correlated with the infarct volume. Histological analysis showed that retrograde atrophy or degeneration of the motor projection neurons in M1 was a candidate for these irreversible changes. This atrophy was observed only during the late stage (3 weeks and later), suggesting that Wallerian degeneration and subsequent atrophy of M1 neurons occurred over several weeks after ET-1 injection. Although atrophy or degeneration has also been observed in the M1 neurons of macaques after creation of a lesion in the lateral corticospinal tract (l-CST) at the cervical spinal cord [33, 37] , it was less severe than that in the present ET-1-injected macaques: the percentage of neuronal cell bodies larger than 500 μm 2 was 6.6% in the macaques 3 months after l-CST lesion [33] , whereas the median percentage was 0 in the ET-1-injected macaques. This difference may reflect the possibility that neurons subjected to insult close to the cell body are more susceptible to damage than those subjected to insult far from the cell body [38] . The present model is thus appropriate for investigating selective neuronal loss that occurs in preserved tissue after stroke [39] . We previously compared the motor recovery of macaques that had received intensive motor training with those that received no training after the creation of M1 lesions, and showed that the recovery of precision grip could be promoted by post-lesion training [1] . The behavioral changes in the present ET-1-injected macaques were similar to those of M1-lesioned macaques without post-lesion training, in that gross hand movements recovered whereas dexterous movements, including precision grip, did not recover to preinjection levels. A study of the effects of post-lesion rehabilitative training in ET-1-injected monkeys is an important next step.
Finally, we should point out that the present ET-1 injection model does not exactly reproduce the human pathophysiology of lacunar infarction. Although the majority of the lacunar infarcts in human patients are caused by occlusion of a single penetrating vessel, ET-1 injection caused several microvessels to be constricted simultaneously [40] [41] [42] [43] . Additionally, ET-1 is localized not only to vascular endothelial cells but also to neurons and astrocytes in the brain [44] [45] [46] [47] , and the receptors for ET-1 are expressed in activated astrocytes and microglia as well as vascular endothelial cells [48, 49] . Thus, ET-1 may also modulate the functions of neurons and glia. Because of these limitations, the present ET-1 injection model is not suitable for investigating the acute phase of infarction, but is better suited for studying the progression of neurological damage and the recovery of function that occurs during chronic stages after white matter infarcts in primates. A recent internal capsule stroke model in the rat and common marmoset showed long-lasting motor deficits that persisted for at least 1 month and 10 days, respectively [12, 17] . The present study followed the macaques for 3 months after ET-1 injection and confirmed that impairment of dexterous hand movements remained until the end of the behavioral and imaging experiments at 3 months. Thus, the present model may have an advantage over other experimental models in testing therapeutic interventions that last for several months, such as rehabilitative training, after white matter infarcts.
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